Skip to content

Clinical trials

Hepatitis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Country / region: Australia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20122
20135
20152
20171
20181
20192
20202
20213
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status3
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
Kirby Institute5
Human Genome Sciences Inc.2
Macfarlane Burnet Institute for Medical Research and Public Health Ltd2
Vir Biotechnology, Inc.2
Arbutus Biopharma Corporation1
AusperBio Therapeutics Inc.1
Brii Biosciences Limited1
GlaxoSmithKline1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis23
Hepatitis C10
Hepatitis B8
Hepatitis B, Chronic7
Hepatitis C, Chronic4
Digestive System Diseases2
Hepatitis, Chronic2
Hepatitis, Viral, Human2
Liver Diseases2
Blood-Borne Infections1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.